Our mission - is to facilitate the transition of the Russian pharmaceutical market to develop into mature, be a guide on the course of development of the potential of all the pharmaceutical market participants, thereby improving the quality of life for the end user and society in general. Despite the relatively high susceptibility to Russia's external economic and financial risks, imbalances in the domestic policy and great social disparities, the pharmaceutical market in Russia has had a stable positive growth for the last few years.
March 21-23, 2019 in Moscow will be the annual 4th International Forum of Anti-Coagulant and Antiaggregant Therapy (FACT-2012), the most important for the development and promotion of professional assistance to patients with thromboembolic complications event.
The Council of the Eurasian Economic Commission (ECE) has supplemented the rules for registration and examination of medicines for medical use in the Eurasian Economic Union, BelTA informs, citing the press service of the ECE.
The Ministry of Health intends to oblige manufacturers of medical devices (MIs) to conduct clinical trials (CI) in two medical organizations - before registration and when making changes in the regulatory authority. The novelty will affect MI of various categories - from stents and tomographs to adhesive plasters. Industry participants do not agree with the agency's proposals - they are afraid of delay in entering the market of products and additional costs for testing.
The Ministry of Health of Russia has published a draft Federal Law on Amendments to the Federal Law "On the circulation of medicinal products" with regard to the information contained in the State Register of medicines on preparations that have passed state registration with a view to further forming a common information resource of the member states of the Eurasian Economic Union.
The Council under the President of the Russian Federation for the Development of Civil Society and Human Rights (HRC) prepared recommendations on the results of the 58th special meeting on the topic "Actual issues of drug provision of the population".
The State Duma Committee on Health Protection did not support the draft law "On Amendments to the Federal Law" On the circulation of medicines "at a meeting on June 14. The document specifies the time period for the cancellation of state registration of a medicinal product and its exclusion from the state register of medicinal products in the event of the absence of a drug in circulation in the Russian Federation.
On June 6, the Ministry of Agriculture of the Russian Federation published Order No.0101 of 06.03.2018 "On approval of rules for preclinical research of a medicinal product for veterinary use, clinical study of a medicinal preparation for veterinary use, bioequivalence of a medicinal preparation for veterinary use". The document was registered with the Ministry of Justice on 05/06/2018, No. 51296.
According to the analytical company DSM Group, for the first four months of 2018 the volume of the commercial drug market increased by 5.8% in rubles compared to the same period last year. In comparison with March, the market decreased by 9.2%, and compared to April 2017 - increased by 6.2%.
The Ministry of Health of the Russian Federation has developed and submitted for public discussion on the website regulation.gov.ru the draft resolution of the Government of the Russian Federation "On the Approval of the Rules for Granting and Distributing Subsidies from the Federal Budget to the Budgets of the Subjects of the Russian Federation for Arranging for Persons Affected by Life- leading to a reduction in the life expectancy of citizens or their disability, drugs and specialized products of therapeutic nutrition ".